Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy

OBJECTIVE: Erythropoietin (Epo) is neuroprotective in animal models of neonatal hypoxic-ischemic encephalopathy. We previously reported a phase I safety and pharmacokinetic study of Epo in neonates. This paper presents the neurodevelopmental follow-up of infants who were enrolled in the phase I clin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Neurol
Päätekijät: Rogers, Elizabeth E., Bonifacio, Sonia L., Glass, Hannah C., Juul, Sandra E., Chang, Taeun, Mayock, Dennis E., Durand, David J., Song, Dongli, Barkovich, Anthony J., Ballard, Roberta A., Wu, Yvonne W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402201/
https://ncbi.nlm.nih.gov/pubmed/25439577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2014.08.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia